Almac Tops Off New North American Headquarters
March 18, 2009
Staff and management from Almac gathered at the site of their new North American headquarters yesterday along with representatives from construction firm Skanska for a traditional ‘topping off’ ceremony to celebrate the last piece of framing steel being put into place on the new $78m building.
Located on a 40-acre site in Lower Salford, Pennsylvania, the project will include a 166,600-square-foot facility housing clinical supply warehouse/storage, packaging, shipping and receiving, label control areas, as well as a second 75,000-square-foot facility housing administration, communication and the network operations center. Designed by Francis Cauffman, both buildings are expected to be fully operational in 2010.
Speaking at the ceremony, Robert Dunlop, President of Almac Clinical Services said: “We are very pleased with the remarkable progress of our North American Headquarters project, and would like to congratulate Skanska project management and the entire construction team on reaching this major milestone. The completion of Almac’s new North American Headquarters facility will support our continuing business growth and better enable the fulfillment of Almac’s mission to advance human health by bringing new drugs to market sooner.”
Edward Szwarc, Skanska’s Area General Manager said: “This is an exciting day for Pennsylvania’s pharmaceutical and biotech industry, as Almac’s new North American headquarters is that much closer to being finished on time. The completion of this project will bring hundreds of new jobs into the region, in addition to the near 500 created during the construction phase. We look forward to working with Almac and Souderton officials to wrap up this important project.”
The new headquarters are expected to open in 2010 and over 760 people will be employed at the site.
+ 44 (0) 2890 339949
About Almac Group:
The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, formulation development, clinical trial supply and technology (IVRS/Web/EDC), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.
The company employs over 2,400 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Construction of the company’s new $112m North American Headquarters started in July 08 and is expected to be completed 2010.
Skanska USA Building Inc. is a leading national and local provider of construction, pre-construction consulting, general contracting and design-build services to a broad range of U.S. industries including science and technology, healthcare, education, high-tech, aviation, transportation and sports and entertainment. SkanskaUSABuilding also provides pharmaceutical validation services to clients. The company, part of the Skanska AB global group of companies, is headquartered in Parsippany, N.J., and has approximately 4,700 employees.
Skanska is one of the world’s leading construction groups with expertise in construction, development of commercial and residential projects and public-private partnerships. The Group currently has 60,000 employees in selected home markets in Europe, in the U.S. and Latin America. Headquartered in Stockholm, Sweden, and listed on the Stockholm Stock Exchange, Skanska’s sales in 2007 totaled $20 billion.